23andMe Holding Co. (MEHCQ)
OTCMKTS · Delayed Price · Currency is USD
4.330
-0.030 (-0.69%)
Jun 23, 2025, 4:00 PM EDT

23andMe Holding Co. Company Description

23andMe Holding Co. operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally.

The company provides personal genome service (PGS) that consists of a suite of genetic reports, including information on customers’ genetic ancestral origins, personal genetic health risks, and chances of passing on certain rare carrier conditions to their children, as well as reports on how genetics can impact responses to medications.

It also operates Lemonaid telehealth platform to access affiliated licensed healthcare professionals for medical consultation and treatment for various common conditions; offers non-controlled medications for treatment of acute and chronic conditions; and provides Ozempic and Wegovy through its weight loss program, offering consumers with access to affordable weight management care.

In addition, the company provides research services. 23andMe Holding Co. was founded in 2006 and is headquartered in San Francisco, California.

23andMe Holding Co.
Country United States
Founded 2006
Industry Diagnostics & Research
Sector Healthcare
Employees 265
CEO Joseph Selsavage

Contact Details

Address:
870 Market Street
San Francisco, Delaware 94102
United States
Phone (650) 938-6300
Website 23andme.com

Stock Details

Ticker Symbol MEHCQ
Exchange OTCMKTS
Share Class Class A Shares
Fiscal Year April - March
Reporting Currency USD
SIC Code 8071

Key Executives

Name Position
Joseph Anthony Selsavage Interim Chief Executive Officer, Chief Financial and Accounting Officer
Anne Wojcicki Co-Founder and Director
Guy Chayoun Vice President, General Counsel and Corporate Secretary
Tracy Keim Chief Marketing Officer
Savita Pillai Vice President of People
Kent Hillyer Vice President of Consumer Operations
Daniel Chu Chief Product Officer
Frank Russo Chief Security Officer
Matthew E. Kvarda Chief Restructuring Officer
Adam Auton Ph.D. Vice President of Human Genetics